Efficacy and Safety Study of Rifaximin Vaginal Tablets in Bacterial Vaginosis
Stopped According to the Recommendation of the Indipendent Data Monitoring Committee
Conditions
Interventions
- DRUG: RIFAXIMIN VAGINAL TABLET 25 MG
- DRUG: RIFAXIMIN VAGINAL TABLET 100 MG
- DRUG: PLACEBO VAGINAL TABLET
- DRUG: METROGEL VAGINAL
Sponsor
Alfasigma S.p.A.
Collaborators